Silence Therapeutics PLC (NAS:SLN)
$ 22.33 1.19 (5.63%) Market Cap: 1.04 Bil Enterprise Value: 973.87 Mil PE Ratio: 0 PB Ratio: 41.35 GF Score: 43/100

Silence Therapeutics PLC at Cowen Healthcare Conference (Virtual) Transcript

Mar 01, 2021 / 03:20PM GMT
Release Date Price: $25.25
Anvita Gupta
Cowen and Company, LLC, Research Division - Research Analyst

Awesome. Good morning, everyone. Welcome to Cowen's 41st Annual Healthcare Conference. I'm Anvita Gupta from the biotech research team here, and I'm delighted to introduce Silence Therapeutics for this corporate presentation.

With us today, we have Mark Rothera, President and CEO of Silence. (Operator Instructions)

And so with that, the floor is all yours, Mark.

Mark Andrew Rothera
Silence Therapeutics plc - President, CEO & Executive Director

Thank you, Anvita. And thank you, Cowen, for the invitation. I'm delighted to be here today.

Silence is in a tremendous place. It's a precision medicines company, working in the RNAi arena. And for various reasons that I'll go through, I think it's really poised to take off.

If we go to the next slide, please. During the course of this presentation, I'll make some forward-looking statements. Thank you.

Next slide. So as I was mentioning, I think this year is a really important year in the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot